NCT04052672

Brief Summary

DEFINIT-P is a prospective pilot study of frailty in cardiac device recipients, comprised of a registry and randomized control trial. The RCT is a supervised exercise program and nutritional supplement intervention for pre-frail and frail cardiac device participants. The registry will be used to describe all cardiac device recipients, regardless of frailty status.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Nov 2019

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 22, 2019

Completed
21 days until next milestone

First Posted

Study publicly available on registry

August 12, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

November 1, 2019

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2020

Completed
Last Updated

August 23, 2022

Status Verified

August 1, 2022

Enrollment Period

1.2 years

First QC Date

July 22, 2019

Last Update Submit

August 19, 2022

Conditions

Keywords

ExerciseNutritional SupplementPhysical FunctionQuality of LifeCardiac DevicePhysical ActivityDefibrillatorsPacemakersBiomarkers

Outcome Measures

Primary Outcomes (4)

  • Rate of identification of eligible patients

    The primary outcome will be the number of patients that meet eligibility criteria.

    1 year

  • The proportion of eligible patients consenting to participate and randomized

    The number of eligible patients that agree to participate in the randomized control trial and the number of eligible patients that consent to participate in the observational trial

    1 year

  • The change in the rate of adherence to the trial interventions from baseline to 12 months

    The intervention adherence of both the exercise intervention and nutritional supplement

    3 months, 6 months, 1 year

  • Barriers and facilitators of adherence to the intervention

    The identification of barriers to exercise and nutritional supplement adherence

    1 year

Secondary Outcomes (5)

  • Frailty biomarker levels

    1 year

  • Physical activity levels as measured by the cardiac device (Permanent pacemaker or Implantable cardioverter defibrillator)

    1 year

  • Myocardial infarction, stroke, heart failure hospitalization, atrial fibrillation or ventricular tachyarrhythmia

    1 year

  • Cardiac device complications

    1 year

  • Injury from a fall or fractures

    1 year

Study Arms (2)

Randomized Intervention

ACTIVE COMPARATOR

The intervention will consist of an exercise intervention, a combination of supervised exercise classes and in home exercises and open label nutritional supplement.

Other: Exercise and Nutritional Supplement

Randomized - Control

NO INTERVENTION

The control will consist of a single group educational session which will include the discussion of general advice on health, exercise and nutrition as well as open label nutritional supplement

Interventions

The intervention consists of exercise (a combination of supervised and in home) as well as a nutritional supplement (a combination of whey protein and creatine).

Randomized Intervention

Eligibility Criteria

Age55 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Permanent pacemaker recipients OR
  • Implantable cardioverter defibrillator recipients

You may not qualify if:

  • Age \<55 years, or
  • Unwilling to consent
  • Patients will be eligible for the registry but not eligible for the randomized control trial if they fulfill any of:
  • Are non-frail
  • Already undertaking \>1 hour per week of dedicated exercise
  • Existing or prior referral for cardiac rehabilitation
  • Moderate or severe heart failure (New York Heart Association class III or IV)
  • Unstable angina
  • Any other medical condition that will prevent exercise participation
  • Dementia, as identified by a Mini-Mental State Examination score \<25

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hamilton General Hospital

Hamilton, Ontario, L8L 2X2, Canada

Location

MeSH Terms

Conditions

FrailtyCardiovascular DiseasesMotor Activity

Interventions

ExerciseDietary Supplements

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Darryl Leong, PhD. MBBSm

    McMaster University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 22, 2019

First Posted

August 12, 2019

Study Start

November 1, 2019

Primary Completion

December 30, 2020

Study Completion

December 30, 2020

Last Updated

August 23, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations